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Abstract 
 
Background 
Previous imaging studies have suggested links between brain pathologies and factors 
that are associated with falls such as gait, balance and daily function. Possible 
neuropathological correlates of older people’s falls have been suggested based on 
brain imaging studies, but to date none have been examined in brain tissue. 
 
Methods 
Falls data collected from repeated surveys of a population-based cohort of individuals 
aged at least 75 years old at baseline were related to neuropathological data collected 
from post-mortem examination of the study’s associated brain donor collection 
(n=212). 
 
Results 
Amongst people without dementia, most cerebrovascular neuropathological features 
examined, particularly white matter pallor, microinfarcts and microscopic 
atherosclerosis, were increasingly common across the sub-groups categorised by no 
reports of falling, only one or at least two reports of falling. The overall burden of 
pathology was greater in those with dementia, but only microinfarcts showed a similar 
increase with respect to reported falling status.  
 
Conclusions 
Subclinical pathologies sharing a common vascular origin are associated with 
increased falling amongst people with no dementia, as are microinfarcts in those with 
dementia. Although further research is needed to address the mechanisms of falls and 
their neuropathological correlates, the findings from the current study would suggest 
that if cerebrovascular disease prevention reduces vascular neuropathology changes 
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this may have direct benefits in reducing falls amongst older people with or without 
dementia.  
 
Abstract:  222 words
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Background 
 
Falling is common in old age, particularly in older old age and in individuals with 
dementia (1, 2). Falls amongst older people are a growing public health concern as 
demographic trends forecast an increasingly ageing population (3). The aetiology of 
falls is multi-factorial and the neuropathological contributions to factors associated with 
mobility impairments such as gait changes and poor balance are not clear (4). 
 
Various imaging studies have suggested links between subclinical brain pathologies, 
such as white matter changes, brain atrophy and ischaemic lesions, and factors that 
are associated with falls in the older population, such as gait disorders, impaired 
balance, postural instability and other measures of daily function (5-7).  
 
White matter lesions, seen as hyperintensities on MRI and hypointensities on CT, 
include a variety of lesion types that may be markers for cerebrovascular disease (8-
10). Neuropathologically, these lesions include gliosis, expansion of perivascular 
spaces, small diffuse infarcts, lacunar infarcts, axonal loss and demyelination (11).  
 
Total volume of white matter abnormalities seen on MRI has been associated with gait 
disturbance (5, 12-18), balance impairments (5, 13-15, 19, 20), increased tendency to 
fall (17, 18, 21, 22) and hip fracture (23). While some studies have demonstrated an 
association between decreased mobility and lesions located in deep white matter (24), 
others have found this more strongly associated with periventricular lesions (25, 26), 
and a recent study suggested that both locations were independently associated with 
gait impairments and falls(27) 
 
Brain atrophy, as evidenced by ventricular enlargement (20, 21, 25, 28) and grey 
matter volumes measured on MRI (29), has been associated with gait disturbances 
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and balance impairments. This association may be independent from white matter 
lesions(28, 29).  
 
Small subcortical infarcts, lacunes and ischaemic lesions in the basal ganglia have 
also been associated with decreased mobility (21, 24, 30, 31). While neuroimaging 
studies easily detect lacunes and small infarcts (>3mm) in white matter, microinfarcts 
in grey matter  are not so easily detected (32) and may be better analysed in post 
mortem brain tissue. Microinfarcts in grey matter at autopsy have been associated with 
cognitive decline (32, 33) but, to our knowledge, have not been examined in brain 
tissue with respect to falls in older persons. 
 
In the current study, we sought to explore the relationship between falls data collected 
from repeated surveys of a population-based cohort aged at least 75 years at baseline 
and findings from post-mortem examination of the study’s associated brain donor 
collection. In addition to the possible neuropathological correlates suggested by 
neuroimaging studies, we investigated the effects of tau reactive tangles in the 
substantia nigra which have previously been associated with gait disorders (34, 35). 
 
 
Methods 
 
The cohort sample: recruitment, assessments and brain donation 
The Cambridge City over-75s Cohort (CC75C) study is a longitudinal population-based 
study of cognition and function in older old age with an associated brain donation 
programme for examination of neuropathological correlates of changes with ageing 
(www.cc75c.group.cam.ac.uk; (36, 37)). It began in the mid-1980s with a survey of 
dementia prevalence amongst men and women aged at least 75 recruited from six 
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general practices to provide a socially representative sample of all older residents of 
Cambridge, UK. The baseline response rate was 95% (n=2166) and over the 23 years 
of follow-up to date, with repeated interview waves every few years, the main cause of 
attrition has been mortality. In the initial phase of the study, the full-sample surveys 
were followed by intensive examination of sub-samples using the Cambridge 
Diagnostic Examination for the Elderly (38) (39), a psychiatrist administered 
assessment that also includes a proxy informant interview. Participants were sampled 
for intensive CAMDEX interviews (94% participation rate) on the basis of Mini-Mental 
State Examination (40) (MMSE) scores: all scoring MMSE 0-23, suggesting low to 
moderate cognitive function, and 1 in 3 with MMSE scores 24-25, suggesting mild or 
minimal cognitive impairment.  
 
CC75C is one of the three European population-based studies with brain donation 
programmes that form EClipSE (Epidemiological Clinicopathological Studies in Europe 
www.eclipsestudy.eu).  Approaching participants to raise the possibility of donation to 
the study’s brain collection began shortly after the second full survey, known then as 
the Cambridge Project for Later Life (CPLL), focussing initially on those who had 
completed CAMDEX assessments. The recruitment methods and high rates of 
consent from participants, assent from relatives and successful collection have been 
previously reported after this initial phase (41). Subsequently participants whose 
MMSE scores suggested normal to high cognitive function were also recruited to the 
brain donation programme to ensure the sample would reflect the full population 
spectrum. Although clinically diagnosed dementia assessments could not be made for 
the full cohort, the distribution of MMSE scores in the baseline sample closely matches 
those of the brain donor sample.  Besides the in-depth CAMDEX assessments made 
on many donors, retrospective interviews were sought with relatives at least six 
months after a donor’s death to obtain further information on the period elapsed since 
a participant was last interviewed until they died.  
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A consensus diagnosis for dementia status at death for all brain donors was agreed by 
two clinicians (CB, TD) blinded to neuropathology findings using post-mortem review 
of all interviews including proxy informant data and death certificates. Dementia status 
was defined as mild or more severe dementia versus minimal or no dementia. Minimal 
dementia refers to the CAMDEX category of that name(39), a limited and variable 
cognitive impairment falling short of a clinical diagnosis of dementia. Dementia status 
from clinical diagnosis has been described in detail elsewhere(42). 
 
Measures of falling 
The CC75C study in later surveys has included a focus on falling in advanced old age 
(43), but all surveys have collected at least minimal falls data. At baseline and in the 
early follow-up interviews falls were included in a section on physical health problems 
in general with questions “What particular difficulties do you have?” and “Have you 
recently had an illness or condition which prevented you carrying out your normal day-
to-day routine?” referring to the previous month. The list of possible disabling 
conditions that followed always included being “unsteady on your feet”; the listed 
wording “falls” was changed to “tendency to fall” from Survey 3 (year 7) onwards. A 
new set of questions specifically on falls was added at Survey 4 (year 10), from which 
point on interviewees were asked to recall whether they had fallen in the three months 
before interview and, if so, how many times. An intensive prospective data collection 
monitored falls for 12 months after Survey 6 (year 17 when the surviving participants 
were all in their 90s) and information was also gathered on recalled falls in the year 
before that interview. Falls were explicitly defined for this survey according to the 
Kellogg International Working Group on Prevention of Falls in Older People (44), but 
this had not been made specific in earlier surveys. Proxy informants were asked for 
the same information whenever they provided supplementary survey data, CAMDEX 
relative interviews or retrospective informant interviews. 
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All these sources of falls data have been used to classify the brain donor sample into 
three groups: people for whom no falls nor any tendency to fall was ever reported, 
people for whom there is only one such report and people with at least two such 
reports. One person who died shortly after the baseline survey with a positive 
response to only one fall question was excluded from the analysis as their limited 
participation could have led to their misclassification. The remaining sample has fall 
information completed on at least two occasions. 
 
Neuropathology protocol 
After death, the brains were removed as soon as possible in the local mortuary. The 
brains were cut in the sagittal plane. One hemisphere was dissected coronally into 
approximately one cm slices, macroscopically examined, and the slices were snap 
frozen at -80C. Gross atrophy was assessed by eye by an experienced 
neuropathologist as none, mild, moderate or severe. Measures of the degree of sulcal 
widening and the degree of ventricular enlargement were recorded as none, mild, 
moderate or severe separately for frontal, parietal, temporal and occipital cortices and 
for the hippocampus and cerebellum. Macro-vascular burden was assessed by the 
number, size and location of visible macro-vascular lesions in any area. 
 
The other half of the brain was dissected coronally into approximately 1 cm slices and 
formalin fixed for at least six weeks. For diagnostic purposes, blocks for paraffin 
embedding were taken from: hippocampus (at the level of the lateral geniculate body), 
entorhinal cortex (at the level of the mamillary body), frontal, temporal, parietal, and 
occipital lobes, basal ganglia, thalamus, pons, medulla, cerebellum and from two 
levels of the midbrain. The tissue blocks included cortical and subcortical white matter, 
deep cerebral white matter and the internal capsule. 
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Ten micrometer thick sections were stained with haematoxylin and eosin to 
qualitatively assess neuronal loss, perivascular gliosis, presence of microinfarcts and 
microvascular appearance in each area. Separate scores were recorded in white and 
grey matter for V-R space expansion, perivascular gliosis and microinfarcts. Tau and 
Lewy body pathology was assessed on immunohistochemical preparations using 
antibodies obtained from the Cambridge Brain Bank Laboratory. Anti-tau antibody 
(mAb 11.57) was used to immunostain neurofibrillary tangles, neuritic plaques and 
dystrophic neuirtes. Slides stained with anti-ubiquitin antibody (pAb BR 251; DAKO 
Z0458, early cases n=174) or anti-α-synuclein (Biomol International SA3400, later 
cases n=50) and slides stained with haematoxylin and eosin were used to detect Lewy 
bodies. All immunostained sections were counterstained with Ehrlich’s haematoxylin 
with diaminobenzidine as the chromagen. 
 
Ratings for tau-reactive tangles per section in the substantia nigra were graded as 
none (no tangles), mild, (one or two) moderate (three to five) and severe (five plus) 
according to the Consortium to Establish a Registry of Alzheimer’s disease (CERAD) 
(45), protocol. Microinfarcts were scored as present or absent, whereas other 
microvascular lesions were rated as severe or not severe in all areas. Lewy bodies 
were assessed by their presence or absence in entorhinal, hippocampal, frontal and 
temporal cortices and in substantia nigra, nucleus basalis, dorsal raphe nucleus, locus 
coeruleus and dorsal vagal nucleus. White-matter pallor was rated as severe or not 
severe in occipital, parietal, frontal, temporal cortices and in deep white matter and the 
internal capsule. All assessments were performed blind to clinical status by JHX and 
neuropathologists at Addenbrooke’s Hospital, Cambridge UK.  
 
 
Statistical methods 
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As of October 2008 the first 224 donations in the CC75C brain donor program had 
complete neuropathology report data available for analysis (dataset version 3.0). Of 
these, 11 were excluded from this analysis due to insufficient evidence from interview 
data to make a clinical diagnosis of dementia.  One further participant was excluded as 
described above because only one response to the falling questions was available.  
This left 212 individuals in the analysis. 
 
The frequencies of the identified neuropathological variables were examined across 
dementia and falling status. Ordinal logistic regression by falling status was performed 
for those neuropathological variables that had sufficient numbers with pathology. The 
proportional odds assumption was examined via the Brant test (46). In addition, odds 
ratios were estimated adjusted for age, stroke history and dementia. History of a 
stroke was obtained from self-report or proxy-report in the surveys or proxy-report in 
the retrospective informant interviews or as recorded on the death certificate. As 
differences in risk were observed across the dementia status groups, an interaction 
between each neuropathological variable and dementia was included in each model 
enabling the falling risk to be presented by dementia status. A multivariable model was 
built using a backwards stepwise approach (p=0.1) from those variables with p-values 
in the adjusted analysis of less than 0.2. Three sensitivity analyses were performed: 
first to exclude those participants with any Lewy bodies identified in the 
neuropathology report; second, to minimise the potential for misclassification in falling 
status by excluding those participants reporting one fall or less whose last fall report 
was greater than two years prior to death; and third, although results were stratified by 
dementia status, in addition MMSE score was adjusted for in case differences in 
cognition in the falling groups affected any neuropathology associations. All analyses 
were conducted in Stata (Intercooled Version 9.2). 
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Results 
 
Table 1 describes the characteristics of the sample. There were 150 (71%) women 
and 62 (29%) men. Age at death ranged from 81 to 106 years, with a mean (SD) of 91 
(4) years, and 53% died with clinical dementia. The mean (SD) length of follow-up was 
10 (4) years and the median (IQR) time from last interview until death was 1.6 (0.8-
2.6) years. Around half of the participants (n=105) had retrospective informant 
interviews providing falling information up to the time of death. This resulted in the 
median time between the last fall reporting and death being less than a month. Most 
participants (n=186, 88%) completed a CAMDEX interview prior to death. From all 
sources, 77% participants had reports of falling on at least one occasion, and 56% had 
reports of falling on two or more occasions. Those reporting repeated falls were more 
likely to be female, to have died slightly older, to have dementia and to have reported 
a stroke during life.  
 
For most neuropathological variables examined more severe pathology was observed 
across the increasing falling groups for those without dementia (table 2). Those with 
dementia tended to have more severe pathology, yet the relationship with falling was 
generally weak and instead a slight decline in pathological severity was observed 
across the increasing falling groups for many variables. The frequencies by dementia 
status for atrophy, microscopic atherosclerosis, white matter pallor, Virchow-Robin (V-
R) space expansion, microinfarcts, and neuronal loss in the substantia nigra are also 
displayed in Figure 1.  
 
Table 3 displays the ordinal odds ratios (ORs) for predicting falling status. 
Arteriolosclerosis was excluded as the proportional odds assumption was violated with 
no evidence of an increasing trend. Only white matter pallor, total microinfarcts, and 
microinfarcts in the grey matter were associated with falling in the naive univariate 
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analyses. However, after adjusting for age and self-reported stroke and allowing the 
OR to vary across dementia status, white matter pallor (overall and in the cortex), 
microscopic atherosclerosis, V-R space expansion in the white matter, microinfarcts 
(overall and in the grey matter) were all significantly associated with more frequent 
falling in those without dementia. In those with dementia only microinfarcts were 
significantly associated with increased falling status and only moderate/severe tangles 
were significantly associated with decreased falling status.  Less frequent falling was 
also observed in those with dementia with moderate or severe enlarged ventricles or 
V-R space expansion in the white matter, but not statistically significantly (p=0.08 and 
p=0.05). In the multivariable model, microinfarcts remained significantly associated 
with more frequent falling in those with dementia, although for those without dementia 
the association decreased and no longer reached statistical significance. White matter 
pallor and microscopic atherosclerosis also remained independently associated with 
more frequent falling, but only in those without dementia. 
 
Excluding the 28 participants with Lewy bodies slightly decreased the ORs in the 
multivariable model for microscopic atherosclerosis and white matter pallor though 
they are consistent with the confidence intervals of the original model. Excluding the 
20 participants reporting at most one fall, but whose last fall report was longer than two 
years prior to death, had a negligible affect on the results. Lower MMSE score at the 
last interview before death was also associated with increased falls in both those with 
and without dementia. However, the neuropathology findings remained unchanged 
after adjustment for MMSE scores (results not shown). 
 
 
Discussion 
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In this analysis examining post-mortem neuropathology related to falling in old age, we 
demonstrate an association between falling and increased frequencies of white matter 
pallor, microinfarcts and microscopic atherosclerosis in individuals without clinical 
dementia. Although the overall burden of pathology was greater in individuals with 
dementia, this generally did not vary significantly by reported falling status. Cortical 
microinfarcts were associated with falling in both the non-demented and to a lesser 
extent the demented group, and this pattern of association was similar in the different 
cortical areas investigated.  
 
This study is one of only a handful of population-based studies worldwide that have a 
long established brain donation collection, one of the longest-running studies of the 
very old and the first to examine potentially relevant post mortem neuropathology 
findings in relation to reported falling in a sizeable cohort of the “older old”. The 
strengths of the study include the neuropathological analyses blind to clinical 
information, the availability of clinical diagnoses of dementia, long period of 
prospective follow-up in the advanced age-group and data on falling from proxy 
informants as well as participants for the majority of donors. The statistical approach 
included multivariable modelling which allowed us to compare the neuropathological 
features simultaneously. The consistency of results from the three sensitivity analyses 
- excluding people whose latest interview data were more than two years before death, 
excluding those with any reported Lewy bodies, and adjusting for MMSE - suggest our 
findings are robust. 
 
There is inevitably some uncertain classification of the sample into the falling groups. 
Data were pooled from a variety of sources - participant and proxy informant 
interviews with questions worded differently over follow-up time. Methodological issues 
in studies of falls are known to be complex (47): it is common in research and clinical 
practice to ask about recent falls, despite the obvious questions concerning recall bias, 
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particularly by people with cognitive impairment (43, 48, 49). The frequency of falls 
reported during the main surveys for those participating in the brain donation 
programme and the remaining CC75C survey were found to be similar once adjusted 
for the number of surveys completed and timing of dropout. Only a minority of the 
CC75C donors (n=12) have died since our 2002-3 survey, which had falling as a 
special focus and included a year’s prospective falls data collection (43), so our 
classification of fall status was based largely on reports of recalled falls, using 
information from proxy informants as well as participants. Moreover the intermittent 
surveys, intensive for some in the study’s initial phase but only every few years later 
on, may have led to `lost’ reports of falling.  This might be particularly so for individuals 
with no retrospective informant interview after death, so any falls at the end of life 
subsequent to last interviews would be unknown. Recent falling has been highlighted 
as the most inconsistent health factor from one interview to the next in longitudinal 
studies of older people (50). Our findings suggesting a trend across fall categories are 
remarkable given that these limitations of the data on falls would be expected to 
weaken any associations detected.  
 
Our study used a neuropathological resource generated from the autopsy diagnostic 
procedure used in the CC75C study. In contrast to other autopsy studies (32, 33), 
areas of interest were sampled only once. This would lead to a lower chance of 
sampling pathology of interest and therefore our results are more likely to be an 
underestimate of any association. Dichotomising the grading of vascular pathology is a 
coarse measure and again may weaken any association.  
 
Amongst the donors with diagnosed dementia the lack of positive association of any 
neuropathological features other than microinfarcts with falling is notable, indeed there 
was suggestion of a negative association for many pathologies. Our analytical 
approach specifically added an interaction term because of the clear distinction in 
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patterns seen when the sample were grouped by dementia status. The more frequent 
reports of falling observed amongst those with a dementia diagnosis are consistent 
with clinical expectations. It may be that the neuropathological burden is so extreme in 
dementia as to outweigh any specific factors affecting motor control, hence few such 
effects can be detected. Clearly there is also the possibility that falls were poorly 
reported by people with dementia, though the attempts to allow for this with proxy 
reporting are discussed above. There is some evidence from fall risk factors research 
that frail older people with the highest levels of impairments – most severe dementia 
and immobility – fall less than those with considerable impairment who maintain some 
limited mobility (51) and our results may reflect this pattern. It may be that those with 
the highest levels of impairments have fewer opportunities to fall. More studies are 
required to clarify this.  
 
There are difficulties comparing our results with MRI studies. Many MRI studies 
present total scores for white matter lesions (WML) without investigating what each 
type of hyperintensity represents. Indeed, it has been previously noted that WML as 
seen on MRI are heterogeneous and require careful classification (52). The various 
white matter lesions seen in MRI have been successfully linked with pathology seen 
after autopsy (11). Further studies to clarify the relationship between lesions seen in 
grey matter with MRI and pathology seen after autopsy are needed. Our semi-
quantitative measures for microinfarcts, gliosis, perivascular space expansion or 
demyelination may not correlate directly to the quantitative measures used in imaging 
studies, making direct comparisons difficult. 
 
Some imaging studies have investigated mobility and function relative to lesions in 
specific locations and have found specific periventricular or deep white effects, though 
the results are conflicting (24, 25, 53, 54). Our measures of presence and/or severity 
for each lesion are limited in this respect. It is not possible to say whether the type, 
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extent or location of lesions found in our study are specific to increased risk of falling 
or whether the lesions affect gait and balance via a more global mechanism involving 
executive function and the frontal-subcortical motor networks(6, 27).   
 
Many of the pathologies associated with gait and balance disturbances are also 
associated with cognitive change, supporting the possibility of global rather than 
specific effects (53). Pathologies associated with falling are neither necessary, as 
shown by a subgroup of falling elderly with no clear pathology (55), nor specific, as 
similar burdens of lesions are shared by patients who develop gait and balance 
disorders and patients who do not (56). The association between falls and cognitive 
impairment, whether diagnosed as dementia or not, is well established (2). That 
neurological mechanisms may be common to both cognition and motor function also 
fits with clinical observation and research evidence that fall risk increases with 
cognitive decline and is linked to performance in dual tasks involving simultaneous 
demands on cognitive and mobility control pathways (57, 58). However, our findings 
remain unchanged when we re-analysed adjusting for MMSE score. A recent 
prospective community study found executive function deficits predicted increased 
falls risk even in healthy older adults (59).  Such findings merit further investigation 
with imaging in population-based samples across the cognitive spectrum, questions 
that new research underway may be able to address (60).  
 
While studies have found associations between tangles in the substantia nigra and 
mobility impairments (34, 35), our results from this region are conflicting: greater 
severity of tangles appeared to be associated with fewer reports of falling amongst 
those with dementia but not in those without dementia, nor were Lewy bodies or 
neuronal loss related to falling in either sub-group. This may simply be a chance 
finding due to sample size or an artefact of measurement error, for instance the under-
estimation of pathology due to the tissue sampling protocol and the coarse measures 
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used. This may also reflect the pattern of fewer falls in those with the greatest 
impairments discussed above. Further studies are needed to replicate or refute these 
anomalous results. 
 
Various studies have found significant associations between atrophy and mobility 
impairments(28) (21) (20). Our measure of association between atrophy and falling is 
small and not significant.  This lack of significance may be due both to the very high 
proportion of the sample in which atrophy was noted and to the imprecision of the 
atrophy rating and again merits further investigation. 
 
Another question for future research is whether our findings in an “older old” cohort 
would differ in younger old people. Hip fractures were independently associated with 
diffuse WML in subjects less than 80 years, but this association was not detected in 
subjects older than 80 (23). In contrast, our study does find an association between 
white matter pallor and falls in donors aged over 80. The prevalence of cognitive 
impairment and dementia close to death has been shown to rise steeply with older age 
(61) and falls are also more common in advance old age (43), but how these clinical 
syndromes interplay with neuropathology is still unclear, as is the relationship between 
neuropathology and dementia in advanced old age (62).  
 
Classification of mobility impairments that may increase the risk of falling in the older 
population is currently unclear in the neuropathology literature. Gait disorders (15, 29) 
vascular Parkinsonism (56), extrapyramidal signs (6) and mild Parkinsonian signs (7) 
are terminologies used to reflect similar gait and balance disturbances. There may be 
continua here crossing diagnostic boundaries related to severity of clinical symptoms. 
The subclinical pathology associated with mobility impairment also lacks rigorous 
terminology. Leukoaraiosis (26), (age related) white matter changes (15) and white 
matter lesions (13, 14) are all terms referring to similar neuropathological lesions in 
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white matter. The lack of solid terminology leads to confusion in the literature and 
clarification is urgently needed.  
 
Many vascular factors were associated with falls in our sub-group without dementia, 
though only microinfarcts were associated with falling in our sub-group with dementia. 
There may be multiple underlying mechanisms with the potential to contribute to 
mobility impairment. Type, extent and location of lesions may have quite distinct 
effects. Although we attempted to differentiate these features we are aware that our 
methods, as with many others’, may not have adequately identified their independent 
and possibly confounding effects. Cerebrovascular disease – the common aetiology 
underlying the factors that our analyses have highlighted – is potentially preventable 
so these findings have important implications. Further studies are needed to advance 
understanding of the mechanisms at work, particularly research comparing in vivo 
imaging with subsequent post-mortem findings in relation to clinical evidence, in order 
that neuro-epidemiology may be translated into public health benefit. 
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Table 1. Characteristics of the neuropathology dataset by falling status at death 
 
 
 Tendency to fall status   
 No report (n=49) One report (n=45) 2+ reports (n=118) Total (N=212) 
Characteristic n (%) n (%) n (%) n (%) 
Sex         
Men 27 (55%) 12 (27%) 23 (19%) 62 (29%) 
Women 22 (45%) 33 (73%) 95 (81%) 150 (71%) 
Dementia status         
No dementia 27 (55%) 23 (51%) 49 (42%) 99 (47%) 
Dementia 22 (45%) 22 (49%) 69 (58%) 113 (53%) 
History of stroke         
No 36 (73%) 27 (60%) 57 (48%) 120 (57%) 
Yes 13 (27%) 18 (40%) 61 (52%) 92 (43%) 
 mean (SD) mean (SD) mean (SD) mean (SD) 
Age at death, years 89.8 (3.6) 90.1 (3.9) 91.8 (4.6) 91.0 (4.3) 
Follow-up time, years 9.1 (3.5) 10.2 (3.1) 10.0 (4.2) 9.8 (3.8) 
 median (IQR) median (IQR) median (IQR) median (IQR) 
Time from last survey to 
death, years 1.6 (0.8 - 2.3) 1.8 (1.0 - 2.5) 1.6 (0.7 - 2.7) 1.6 (0.8 - 2.6) 
Time from last fall report to 
death, months 6.8 (0.0 - 20.3) 0.0 (0.0 - 17.6) 1.1 (0.0 - 13.3) 0.7 (0.0 - 17.9) 
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Table 2. Number of individuals (percentage) with specific neuropathological findings by falling and dementia status 
  
   No dementia  Dementia  Total 
Neuropathological variable No report (n=27) One report (n=23) 2+ reports (n=49)  No report (n=22) One report (n=22) 2+ reports (n=69)  No report (n=49) One report (n=45) 2+ reports (n=118) 
      n % n % n %  n % n % n %  n % n % n % 
Brain atrophy                      
Gross brain atrophy No 6 23 5 22 5 11  0  1 5 6 9  6 13 6 13 11 10 
  Yes 20 77 18 78 41 89  22 100 21 96 61 91  42 88 39 87 102 90 
                       
Enlarged ventricles None 17 65 9 39 14 30  6 27 8 36 24 36  23 48 17 38 38 34 
  Sparse 7 27 12 52 22 48  5 23 6 27 23 34  12 25 18 40 45 40 
  Moderate 2 8 2 9 10 22  9 41 6 27 19 28  11 23 8 18 29 26 
  Severe 0  0  0   2 9 2 9 1 1  2 4 2 4 1 1 
                       
Neocortical widened sulci None 6 22 5 22 3 6  1 5 1 5 7 10  7 15 6 13 10 9 
  Sparse 10 37 10 43 29 59  9 41 6 27 21 30  19 40 16 36 50 44 
  Moderate 10 37 8 35 13 27  9 41 13 59 34 49  19 40 21 47 47 42 
  Severe 0  0  1 2  3 14 2 9 5 7  3 6 2 4 6 5 
                       
White matter pallor                      
 Overall No 21 88 13 59 21 49  8 40 8 38 27 44  29 66 21 49 48 46 
  Yes 3 13 9 41 22 51  12 60 13 62 35 57  15 34 22 51 57 54 
 Cortex No 21 88 13 59 23 54  9 45 8 38 29 47  30 68 21 49 52 50 
  Yes 3 13 9 41 20 47  11 55 13 62 33 53  14 32 22 51 53 51 
 Deep White No 24 100 22 100 38 91  16 80 18 86 54 87  40 91 40 93 92 89 
  Yes 0  0  4 10  4 20 3 14 8 13  4 9 3 7 12 12 
                       
Cerebrovascular disease                     
Macroscopic atherosclerosis None 13 50 10 44 16 34  12 55 6 27 24 37  25 52 16 36 40 36 
  Sparse 6 46 5 39 18 58  5 50 7 44 17 42  11 48 12 41 35 49 
  Moderate 2 6 2 7 5 10  3 13 3 11 13 16  5 9 5 9 18 14 
  Severe 5 16 6 21 8 14  2 8 6 21 11 14  7 13 12 21 19 14 
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Microscopic atherosclerosis No 26 96 20 87 37 76  18 82 18 82 57 84  44 90 38 84 94 80 
  Yes 1 4 3 13 12 25  4 18 4 18 11 16  5 10 7 16 23 20 
                       
Arteriolosclerosis No 7 26 12 52 11 23  3 14 5 23 20 29  10 20 17 38 31 26 
  Yes 20 74 11 48 38 78  19 86 17 77 49 71  39 80 28 62 87 74 
                       
Perivascular gliosis No 25 93 21 96 45 92  20 91 21 96 60 87  45 92 42 96 105 89 
  Yes 2 7 1 5 4 8  2 9 1 5 9 13  4 8 2 5 13 11 
                       
V-R space expansion                      
 Cortex No 16 76 15 79 24 62  11 61 12 63 30 55  27 69 27 71 54 57 
  Yes 5 24 4 21 15 39  7 39 7 37 25 46  12 31 11 29 40 43 
 White matter No 12 57 9 47 9 24  4 22 7 37 26 46  16 41 16 42 35 37 
  Yes 9 43 10 53 29 76  14 78 12 63 30 54  23 59 22 58 59 63 
 Deep grey No 10 48 9 50 11 30  4 22 3 16 21 38  14 36 12 32 32 34 
  Yes 11 52 9 50 26 70  14 78 16 84 35 63  25 64 25 68 61 66 
                       
Microinfarcts                      
 Overall No 18 75 10 46 15 39  10 56 8 42 20 33  28 67 18 44 35 35 
  Yes 6 25 12 55 24 62  8 44 11 58 41 67  14 33 23 56 65 65 
 White matter No 23 96 19 86 32 84  17 94 16 84 47 83  40 95 35 85 79 83 
  Yes 1 4 3 14 6 16  1 6 3 16 10 18  2 5 6 15 16 17 
 Grey matter No 18 75 10 46 16 44  10 56 8 42 22 39  28 67 18 44 38 40 
  Yes 6 25 12 55 22 58  8 44 11 58 35 61  14 33 23 56 57 60 
                       
Substantia nigra                      
 Neuronal loss None 11 41 6 26 19 40  5 23 4 18 27 39  16 33 10 22 46 40 
  Sparse 12 44 12 52 21 45  11 50 11 50 25 36  23 47 23 51 46 40 
  Moderate 4 15 4 17 5 11  6 27 6 27 13 19  10 20 10 22 18 16 
  Severe 0  1 4 2 4  0  1 5 4 6  0  2 4 6 5 
                       
 Any Lewy bodies No 25 93 21 91 43 96  19 86 17 81 61 88  44 90 38 86 104 91 
  Yes 2 7 2 9 2 4  3 14 4 19 8 12  5 10 6 14 10 9 
                       
 Tangles None 18 67 17 74 19 41  5 23 7 32 25 38  23 47 24 53 44 39 
  Sparse 4 15 3 13 18 39  6 27 6 27 23 35  10 20 9 20 41 37 
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  Moderate 2 7 1 4 5 11  8 36 2 9 7 11  10 20 3 7 12 11 
    Severe 3 11 2 9 4 9  3 14 7 32 11 17  6 12 9 20 15 13 
 
* Individuals with missing scores are not included for calculation of percentages. 
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Table 3. Ordinal logistic regression predicting fall status: unadjusted, adjusted and multivariable results 
 
  Unadjusted risks Adjusted* risks  Mulitvariable adjusted** risks 
Neuropathological 
variable OR§ 95% CI p 
Dementia 
status OR§ 95% CI p   OR§ 95% CI p 
Brain atrophy            
Gross brain atrophy 1.3 0.6 - 2.9 0.52 No dementia 2.3 0.8 - 6.3 0.11     
     Dementia 0.2 0.0 - 1.8 0.15     
Moderate/severe enlarged 
ventricles 1.0 0.6 – 1.9 0.90 No dementia 2.7 0.8 - 9.5 0.12     
     Dementia 0.5 0.2 – 1.1 0.08     
Moderate/severe 
neocortical widened sulci 1.0 0.6 – 1.7 0.96 No dementia 0.8 0.3 - 1.8 0.55     
     Dementia 0.9 0.4 – 1.9 0.76     
White matter pallor            
 Overall 1.8 1.0 - 3.0 0.04 No dementia 2.7 1.1 - 6.6 0.02  2.8 1.0 - 7.3 0.04 
     Dementia 0.9 0.4 - 2.0 0.81  0.6 0.2 - 1.4 0.24 
 Cortex 1.6 0.9 - 2.8 0.08 No dementia 2.4 1.0 - 5.7 0.05     
     Dementia 0.9 0.4 - 2.0 0.77     
Cerebrovascular disease            
Macroscopic 
atherosclerosis 1.6 0.9 - 2.7 0.10 No dementia 1.8 0.8 - 4.0 0.15     
     Dementia 1.3 0.6 - 2.8 0.56     
Microscopic 
atherosclerosis 1.7 0.8 - 3.6 0.14 No dementia 4.5 1.4 - 15.0 0.02  3.8 
1.0 - 
14.1 0.04 
     Dementia 0.8 0.3 - 2.1 0.62  0.9 0.3 - 2.9 0.92 
V-R space expansion            
 Cortex 1.6 0.9 - 3.1 0.11 No dementia 2.1 0.8 - 5.6 0.15     
     Dementia 1.4 0.6 - 3.2 0.47     
 White matter 1.2 0.6 - 2.1 0.60 No dementia 2.5 1.0 - 6.2 0.04     
     Dementia 0.4 0.2 - 1.0 0.05     
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 Deep grey 1.0 0.6 - 1.9 0.95 No dementia 1.8 0.7 - 4.5 0.19     
     Dementia 0.5 0.2 - 1.3 0.13     
Microinfarcts            
 Overall 2.6 1.5 - 4.6 0.00 No dementia 2.8 1.2 - 6.4 0.02  1.6 0.6 - 4.0 0.35 
     Dementia 2.3 1.0 - 5.4 0.05  2.7 1.1 - 6.5 0.02 
 Grey matter 2.1 1.2 - 3.8 0.01 No dementia 2.5 1.1 - 5.8 0.03     
     Dementia 1.7 0.7 - 4.0 0.20     
Substantia nigra            
 
Moderate/severe 
neuronal loss 0.9 0.5 - 1.7 0.81 No dementia 1.1 0.4 - 3.2 0.79     
     Dementia 0.8 0.3 - 1.8 0.56     
 Lewy bodies 0.8 0.3 - 1.8 0.60 No dementia 0.9 0.2 - 3.9 0.85     
     Dementia 1.0 0.3 - 2.9 1.00     
 
Moderate/severe 
tangles 0.7 0.4 - 1.3 0.28 No dementia 1.1 0.4 - 3.1 0.90     
          Dementia 0.3 0.1 - 0.7 0.003         
 
 
* Adjusted for age, dementia status, stroke and results stratified by dementia status 
** Adjusted for age, dementia status, stroke and all other variables in the model  
§ Ordinal OR, i.e. the OR of the '2+ falls group' compared to the combined 'no report' and 'one report' groups and the OR of the combined 'one 
report' and '2+ reports' groups to the 'no report' group 
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Figure 1. Proportions of donors with (a) gross atrophy, (b) microscopic atherosclerosis, (c) white matter pallor, (d) cortical V-R space 
expansion, (e) microinfarcts, and (f) neuronal loss in the substantia nigra by falling status in those with dementia (solid line) compared to those 
without dementia (dashed line). 
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Fig 1(b). 
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Fig 1(c). 
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Fig 1(d). 
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Fig 1(e). 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 1 2+
Number of reports of falling
P
e
rc
e
n
ta
g
e
 w
it
h
 m
ic
r
o
in
fa
rc
ts
 
 
neuropathology falls CC75C re-formatted 110730.doc 
 39  
Fig 1(f). 
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